Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability of L-PZQ and Rac-PZQ ODT in African Children
NCT02315352Phase 1Completed
- Sponsor
- Merck KGaA
- Start
- Apr 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of levopraziquantel in schistosomiasis (5 arms), sponsored by Merck KGaA. Primary endpoint: Overall Palatability Visual Analogue Scale Score. Started Apr 2015; status: completed.
02
Drugs
levopraziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT02315352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315352.